Mydimed vs Nucleai

Mydimed vs Nucleai, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Mydimed is on 40/100 and Nucleai on 63/100.

MydimedAI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.
Try Mydimed
Nucleai logo
NucleaiAI-powered spatial biology platform for precision medicine and drug development.
Try Nucleai

Where each one leads

Mydimed

Leads on none of the measures we hold for both companies.

Nucleai

  • our overall score: 63/100 against 40/100
  • agent readiness: 42/100 against 22/100
  • domain rating: 29/100 against 1/100
  • headcount: 66 against 8
  • funding raised: $58.5M against $100K

At a glance

MeasureMydimedNucleai
What it isAI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.AI-powered spatial biology platform for precision medicine and drug development.
CategoryHealthcare, Disease Management, HealthTech, MedTechHealthcare, Oncology, Pharmaceutical, HealthTech
Sells toBusiness modelB2B, B2B2CB2B
OfferingSoftwareSoftware
Founded20162018
HeadquartersNot publishedTel Aviv, Israel
StatusInactiveActive

Size, funding and growth

MeasureMydimedNucleai
Employees866
Headcount growthLast 12 monthsNot published-7.0%
Total funding$100K$58.5M
Latest roundSeedSeries B
LinkedIn followersNot published18,902

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureMydimedNucleai
StartupHub scoreOur 0-100 rating40/10063/100
Traction35/10057/100
TeamNot published70/100
CommunityNot published8/100
Search visibility4/10031/100
Quality55/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (22/100)D (42/100)
Domain ratingLink authority, 0-1001/10029/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureMydimedNucleai
CMSNot detectedWordPress
FrameworksNot detectedJquery
AnalyticsNot detectedGoogle Tag Manager, Linkedin Insight, Facebook Pixel
Support stackNot detectedHubSpot

Mydimed vs Nucleai: common questions

Which is better, Mydimed or Nucleai?

On our 0-100 score Nucleai rates higher (63/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.

How do Mydimed and Nucleai compare on the numbers?

Nucleai leads on our overall score (63/100 against 40/100), agent readiness (42/100 against 22/100), domain rating (29/100 against 1/100), headcount (66 against 8), funding raised ($58.5M against $100K).

Read the full Mydimed review and pricing or the Nucleai review and pricing. You can also browse other Mydimed alternatives we track.